(2E)-2-[6-chloro-10-(4-methylpiperazin-1-yl)-2-tricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,9,11,13-heptaenylidene]acetonitrile

• 分子结构分类: 有机化合物 - 苯类化合物 - 二苯并环庚烯
• 英文名称: (2E)-2-[6-chloro-10-(4-methylpiperazin-1-yl)-2-tricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,9,11,13-heptaenylidene]acetonitrile
• 化学式: C₂₂H₂₀ClN₃
• 分子量: 361.9
• InChiKey: UJCYUJOQBXHJFH-DNTJNYDQSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  26
• 可旋转键数：
  1
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  30.3
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• US4447610A
  申请人：——

  公开号：US4447610A

  公开（公告）日：1984-05-08
• [EN] METHODS AND COMPOSITIONS FOR THE TREATMENT OF SARS-COV-2<br/>[FR] MÉTHODES ET COMPOSITIONS POUR LE TRAITEMENT DU SARS-COV 2
  申请人：SCRIPPS RESEARCH INST

  公开号：WO2021225767A1

  公开（公告）日：2021-11-11

  Disclosed herein are methods that are useful for treating a subject who has a pathogenic infection, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); reducing the likelihood of the subject from being infected by a pathogen; and for reducing the transmission of a pathogen from a subject to others. The methods utilize a compound disclosed in Table 1 or Table 4 herein, optionally in combination with an additional agent such as an anti-infective agent.